The current model for managing chronic obstructive pulmonary disease (COPD) generally considers inhalers from the same therapeutic class to be clinically equivalent.1 When a long-acting muscarinic ...

Patients with COPD had better inhaler adherence when invited to enroll in a program that lowers cost sharing for maintenance inhalers and offers medication management services, according to results ...

Vantage Market Research is pleased to announce the publication of its latest report, Asthma and COPD Drugs Market. This ...

In COPD, 900,000 people have been diagnosed ... "It is important to have a range of different inhaler devices and to find the one that suits that individual person" It is vital to get the correct ...

“Researchers continue studying GLP-1 medications beyond diabetes ... had to do with the weight loss and its effect on COPD, or it had a different mechanism of action. “There’s a lot of ...

Many Part D prescription drug plans cover Trelegy Ellipta, but costs can vary by plan type and insurer. Read more.

The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...

Medicare usually covers the cost of inhalers for people with asthma, COPD, or certain other conditions ... Because insurance companies offer different Part D plans, the medications each plan ...

COPD is a collection of different lung conditions ... The medication is not FDA approved as a rescue inhaler to relieve sudden breathing difficulties. A doctor can give you a separate inhaler ...

“This is important because, right now, inhaled pharmaceutics are designed with a one-size-fits-all approach. But someone who ...